Profil bibliographique

Varunika Savla

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

112Publications signalées

120Citations signalées

2Affiliations récentes

Les institutions déclarées

Brigham and Women's Hospital Harvard University

Les domaines associés

Cancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentCAR-T cell therapy researchImmunotherapy and Immune ResponsesSingle-cell and spatial transcriptomics

Les publications récentes

Accès ouvert 2026 article OpenAlex

Polycomb Scaffolding Subunit EED Supports the SCLC Neuroendocrine Identity and EGFR-Mutant LUAD to SCLC Transformation

Yixiang Li, Yasmin N. Laimon, Hyeonseo Cho, Marina Vivero et autres

us, cn (code pays fourni par la source)

0 citations Journal of Clinical Investigation

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table S9 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table S3 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table S6 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table S4 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table S7 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table S11 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table S10 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Figure S1 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 other OpenAlex

Data from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table S8 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table S5 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Nourhan El Ahmar, Morgan A. Paul, Berkay Şímșek, Sayed Matar et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.